Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RA
Meeting report of a PACE-CME symposium at ERA 2022 on the current and future role of GLP-1RA in the prevention of CKD in patients with T2DM.
Episodes 1-4 of 4
- Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RADiscussion - Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RA
Prof. Johannes Mann, MD
Prof. Filip Knop, MD, PhD
Prof. Katherine Tuttle, MD
- Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RAWhich patients with CKD and diabetes will benefit from management with GLP-1RA?
Prof. Katherine Tuttle, MD
- Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RAWhat is relevant for nephrology with regard to GLP-1RA in CVD?
Prof. Filip Knop, MD, PhD
- Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RANew insights and guidelines for the management of CKD and diabetes
Prof. Johannes Mann, MD